{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,11,14]],"date-time":"2023-11-14T22:10:29Z","timestamp":1699999829330},"reference-count":0,"publisher":"Oxford University Press (OUP)","issue":"16","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Heart Journal"],"published-print":{"date-parts":[[2004,8]]},"DOI":"10.1016\/j.ehj.2004.06.027","type":"journal-article","created":{"date-parts":[[2004,8,5]],"date-time":"2004-08-05T03:00:10Z","timestamp":1091674810000},"page":"1371-1373","source":"Crossref","is-referenced-by-count":6,"title":["Quinidine rehabilitated and more lessons from the PAFAC and SOPAT anti-arrhythmic drug trials for the prevention of paroxysmal atrial fibrillation"],"prefix":"10.1093","volume":"25","author":[{"given":"N","family":"VANHEMEL","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","container-title":["European Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/eurheartj\/article-pdf\/25\/16\/1371\/17887335\/1371.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,8,22]],"date-time":"2017-08-22T22:35:05Z","timestamp":1503441305000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-lookup\/doi\/10.1016\/j.ehj.2004.06.027"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,8]]},"references-count":0,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2004,8]]}},"alternative-id":["S0195668X04004294"],"URL":"https:\/\/doi.org\/10.1016\/j.ehj.2004.06.027","relation":{},"ISSN":["0195-668X"],"issn-type":[{"value":"0195-668X","type":"print"}],"subject":[],"published":{"date-parts":[[2004,8]]}}}